Search all trials

Find therapies in clinical trials near you – page 3

Search by disease and location to discover available clinical trials matching your criteria. Updated every day from authoritative EU registries.

recruiting: 3 961
countries: 28
conditions: 2 103

3 961 trials recruiting28 European countries2 103 conditions coveredUpdated today

Quick filters

Breast cancer+1

Recruiting

Registered drugNo placebo

Study of inavolisib, letrozole and ribociclib in untreated early-stage breast cancer patients with PIK3CA mutation

Registered drugNo placebo

Germany

Participants:18–64 years · 65+ years
Substances:Inavolisib

Contact Research Centre

Breast cancer+3

Recruiting

Registered drugNo placebo

Study on the Safety and Effectiveness of Capivasertib and Fulvestrant for Patients with Advanced HR+/HER2- Breast Cancer After Hormone Treatment

Registered drugNo placebo

Belgium

Participants:18–64 years · 65+ years
Substances:Capivasertib

Contact Research Centre

Breast cancer

Recruiting

Registered drug

Study of inavolisib, palbociclib and letrozole combination for patients with advanced hormone receptor-positive, HER2-negative breast cancer with PIK3CA mutation

Registered drug

France

Participants:18–64 years · 65+ years
Substances:Inavolisib

Contact Research Centre

Breast cancer+3

Recruiting

InvestigationalNo placebo

Study of ETX-19477 for Patients with Advanced Solid Tumors After Standard Treatment

InvestigationalNo placebo

France

Participants:18–64 years · 65+ years
Substances:ETX-19477

Contact Research Centre

Breast cancer+1

Recruiting

Registered drugNo placebo

A Study of Trastuzumab Deruxtecan Treatment for Patients with Early-Stage HER2-Positive or HER2-Low Breast Cancer Who Show Signs of Molecular Relapse

Registered drugNo placebo

Germany

Participants:18–64 years · 65+ years
Substances:Trastuzumab Deruxtecan

Contact Research Centre

Breast cancer+18

Recruiting

InvestigationalNo placebo

Study on the Effectiveness and Safety of BAY 2927088 for Patients with Advanced Solid Tumors with HER2 Mutations

InvestigationalNo placebo

Denmark

Participants:18–64 years · 65+ years
Substances:Bay 2927088

Contact Research Centre

Breast cancer

Recruiting

Registered drugNo placebo

Study of olaparib and chemotherapy combination in stage III breast cancer patients with HER2-negative, hormone receptor impaired or deficient disease

Registered drugNo placebo

France

Participants:18–64 years · 65+ years
Substances:Capecitabine

Contact Research Centre

Breast cancer

Recruiting

Registered drugNo placebo

Study on Low-Dose Gadolinium for Breast Cancer MRI in Patients Using Gadoteric Acid

Registered drugNo placebo

The Netherlands

Participants:18–64 years
Substances:Gadoteric Acid

Contact Research Centre

Breast cancer+2

Recruiting

Registered drugNo placebo

Study on Using Perflubutane for Sentinel Node Detection in Patients with Breast Cancer, Melanoma, or Head and Neck Cancer

Registered drugNo placebo

The Netherlands

Participants:18–64 years · 65+ years
Substances:Perflubutane

Contact Research Centre

Breast cancer+13

Recruiting

InvestigationalNo placebo

Study on Ifinatamab Deruxtecan for Patients with Recurrent or Metastatic Solid Tumors

InvestigationalNo placebo

Belgium

Participants:18–64 years · 65+ years
Substances:Ifinatamab Deruxtecan

Contact Research Centre

Breast cancer+13

Recruiting

InvestigationalNo placebo

Study of JK06 for Patients with Advanced or Metastatic Cancer

InvestigationalNo placebo

Belgium

Participants:18–64 years · 65+ years
Substances:Jk06

Contact Research Centre

Breast cancer+1

Recruiting

Registered drugNo placebo

Study on the Effect of Prasterone on Genitourinary Syndrome in Postmenopausal Women with a History of Breast Cancer or Undergoing Anti-Hormonal Therapy

Registered drugNo placebo

Italy

Participants:18–64 years · 65+ years
Substances:Prasterone

Contact Research Centre

Find therapies in clinical trials near you – page 3

168 trials match your criteria

Breast cancer+1

Study of inavolisib, letrozole and ribociclib in untreated early-stage breast cancer patients with PIK3CA mutation

Breast cancer+3

Study on the Safety and Effectiveness of Capivasertib and Fulvestrant for Patients with Advanced HR+/HER2- Breast Cancer After Hormone Treatment

Breast cancer

Study of inavolisib, palbociclib and letrozole combination for patients with advanced hormone receptor-positive, HER2-negative breast cancer with PIK3CA mutation

Breast cancer+3

Study of ETX-19477 for Patients with Advanced Solid Tumors After Standard Treatment

Breast cancer+1

A Study of Trastuzumab Deruxtecan Treatment for Patients with Early-Stage HER2-Positive or HER2-Low Breast Cancer Who Show Signs of Molecular Relapse

Breast cancer+18

Study on the Effectiveness and Safety of BAY 2927088 for Patients with Advanced Solid Tumors with HER2 Mutations

Breast cancer

Study of olaparib and chemotherapy combination in stage III breast cancer patients with HER2-negative, hormone receptor impaired or deficient disease

Breast cancer

Study on Low-Dose Gadolinium for Breast Cancer MRI in Patients Using Gadoteric Acid

Breast cancer+2

Study on Using Perflubutane for Sentinel Node Detection in Patients with Breast Cancer, Melanoma, or Head and Neck Cancer

Breast cancer+13

Study on Ifinatamab Deruxtecan for Patients with Recurrent or Metastatic Solid Tumors

Breast cancer+13

Study of JK06 for Patients with Advanced or Metastatic Cancer

Breast cancer+1

Study on the Effect of Prasterone on Genitourinary Syndrome in Postmenopausal Women with a History of Breast Cancer or Undergoing Anti-Hormonal Therapy

Explore other searches

Vaccine trials

Paediatric trials · ages 0–17

Healthy volunteers

Helpful resources

How applying through us works

What happens after you apply

Guides for patients and volunteers

Search filters

Prefer not to search? Our Concierge searches the trials for you.